|
Issue |
Title |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
Agricultural Antibiotics and Their Impact on Human Health |
Abstract
PDF
|
Edwin Ruppert |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
ARxCH |
Abstract
PDF
|
Jason W Guy |
|
Vol 2, No 1 (2018): ARxCH |
ARxCH Final Print Version |
Abstract
PDF
|
ARxCH Organization |
|
Vol 3, No 1 (2019): ARxCH |
Benefits and Risk of Aspirin as Primary Prevention of Cardiovascular Disease |
Abstract
PDF
|
Grant Morgan & Thomas Brown |
|
Vol 3, No 1 (2019): ARxCH |
Breakthrough Therapy Designation Awarded to Crizanlizumab, a New Treatment Option for Sickle Cell Disease |
Abstract
PDF
|
Cassandra Kuhn & Olivia Reiber |
|
Vol 2, No 1 (2018): ARxCH |
Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines |
Abstract
PDF
|
Brian Schuler |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
CE: Entresto: An Overview for Pharmacists |
Abstract
PDF
|
David Comshaw |
|
Vol 2, No 1 (2018): ARxCH |
CE: New Insulin/GLP-1RA Agents: Overview for the Pharmacist |
Abstract
PDF
|
Alysa Martin |
|
Vol 2, No 1 (2018): ARxCH |
CE: Overview of the Gestational Diabetes Educational Gap |
Abstract
PDF
|
Erica Hagen, Shiader Thao |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
CE: Review of Human Immunodeficiency Virus and Updated Guidelines |
Abstract
PDF
|
Erica Hagen |
|
Vol 2, No 1 (2018): ARxCH |
CE: Sodium-Glucose Co-transporter 2 Inhibitors: Safety Considerations and Clinical Implications for Healthcare Providers |
Abstract
PDF
|
Gyen Musgrave |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
CE: Summary of 2016 CHEST Guidelines |
Abstract
PDF
|
Emily Doycich |
|
Vol 3, No 1 (2019): ARxCH |
Ceiling dose of Ketorolac in Treatment of Moderate to Severe Acute Pain in an Emergency Department Setting |
Abstract
PDF
|
Nicole Babiak |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
DOAC Reversal Agents |
Abstract
PDF
|
Gyen Musgrave |
|
Vol 3, No 1 (2019): ARxCH |
Electronic Cigarettes: Ongoing Research |
Abstract
PDF
|
Elizabeth Claus & Vivian Lee |
|
Vol 3, No 1 (2019): ARxCH |
GOLD 2018 Report: A Review |
Abstract
PDF
|
Jonathan Mitchell |
|
Vol 3, No 1 (2019): ARxCH |
Overview of Selected Novel Drugs Approved in 2018 |
Abstract
PDF
|
Madison Donnelly & Shawn Hodge |
|
Vol 2, No 1 (2018): ARxCH |
Review of Alzheimer’s Disease Treatment and Potential Future Therapies |
Abstract
PDF
|
Ralf Jadoopat |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
Review of Iron-Overdose in Pediatric Patients |
Abstract
PDF
|
Emily Doycich |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
Review of Parkinson’s Disease Treatment and Future Therapies |
Abstract
PDF
|
Eric Manning |
|
Vol 3, No 1 (2019): ARxCH |
The ARxCH Print Edition 2019 |
Abstract
PDF
|
Grant Morgan |
|
Vol 1, No 1 (2017): ARxCH Issue 1 |
The Rising Incidence of C. difficile and Bezlotoxumab: The Targeting of Toxin B |
Abstract
PDF
|
Brian Schuler |
|
Vol 3, No 1 (2019): ARxCH |
The Watchman Device: An Alternative Treatment in Atrial Fibrillation |
Abstract
PDF
|
Anastasia Palmer, Ahmed Mohamed, & Shiader Thao |
|
1 - 23 of 23 Items |
|